- Home
- SUPN vs VSEC Comparison
SUPN vs VSEC Comparison
Compare SUPN & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- VSEC
- Stock Information
- Founded
- SUPN 2005
- VSEC 1959
- Country
- SUPN United States
- VSEC United States
- Employees
- SUPN N/A
- VSEC N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- VSEC Military/Government/Technical
- Sector
- SUPN Health Care
- VSEC Consumer Discretionary
- Exchange
- SUPN Nasdaq
- VSEC Nasdaq
- Market Cap
- SUPN 1.7B
- VSEC 2.1B
- IPO Year
- SUPN 2012
- VSEC N/A
- Fundamental
- Price
- SUPN $32.90
- VSEC $128.32
- Analyst Decision
- SUPN Hold
- VSEC Strong Buy
- Analyst Count
- SUPN 2
- VSEC 6
- Target Price
- SUPN $36.00
- VSEC $118.67
- AVG Volume (30 Days)
- SUPN 787.3K
- VSEC 278.6K
- Earning Date
- SUPN 05-07-2025
- VSEC 05-07-2025
- Dividend Yield
- SUPN N/A
- VSEC 0.32%
- EPS Growth
- SUPN 6500.00
- VSEC N/A
- EPS
- SUPN 1.32
- VSEC 0.85
- Revenue
- SUPN $661,817,000.00
- VSEC $1,080,132,000.00
- Revenue This Year
- SUPN N/A
- VSEC $11.84
- Revenue Next Year
- SUPN $8.67
- VSEC $10.43
- P/E Ratio
- SUPN $24.90
- VSEC $147.67
- Revenue Growth
- SUPN 8.94
- VSEC 25.53
- 52 Week Low
- SUPN $25.53
- VSEC $73.36
- 52 Week High
- SUPN $40.28
- VSEC $128.72
- Technical
- Relative Strength Index (RSI)
- SUPN 46.17
- VSEC 68.55
- Support Level
- SUPN $31.69
- VSEC $117.40
- Resistance Level
- SUPN $32.90
- VSEC $116.59
- Average True Range (ATR)
- SUPN 0.96
- VSEC 4.52
- MACD
- SUPN 0.29
- VSEC 0.73
- Stochastic Oscillator
- SUPN 89.25
- VSEC 99.76
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.